Terms: = Gastric cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Treatment
12 results:
1. Comparison of treatment Outcomes of Endoscopic Stenting and Laparoscopic Gastrojejunostomy for Malignant gastric Outlet Obstruction.
Leiyuan S; Jianli X; Zhengzhong Z; Guangyan J; Dailiang Z
Am Surg; 2018 Jun; 84(6):991-995. PubMed ID: 29981637
[TBL] [Abstract] [Full Text] [Related]
2. Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive fhit knockout mouse.
Paisie CA; Schrock MS; Karras JR; Zhang J; Miuma S; Ouda IM; Waters CE; Saldivar JC; Druck T; Huebner K
Cancer Sci; 2016 Apr; 107(4):528-35. PubMed ID: 26782170
[TBL] [Abstract] [Full Text] [Related]
3. Aberrant gene promoter methylation of p16, fhit, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract] [Full Text] [Related]
4. Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer.
Cho IR; Park JC; Park CH; Jo JH; Lee HJ; Kim S; Shim CN; Lee H; Shin SK; Lee SK; Lee YC
Gastric Cancer; 2014 Oct; 17(4):703-10. PubMed ID: 24442663
[TBL] [Abstract] [Full Text] [Related]
5. MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas.
Ha SY; Lee J; Kang SY; Do IG; Ahn S; Park JO; Kang WK; Choi MG; Sohn TS; Bae JM; Kim S; Kim M; Kim S; Park CK; Ignatius Ou SH; Kim KM
Mod Pathol; 2013 Dec; 26(12):1632-41. PubMed ID: 23807774
[TBL] [Abstract] [Full Text] [Related]
6. Correlation of fragile histidine triad (fhit) protein structural features with effector interactions and biological functions.
Pichiorri F; Okumura H; Nakamura T; Garrison PN; Gasparini P; Suh SS; Druck T; McCorkell KA; Barnes LD; Croce CM; Huebner K
J Biol Chem; 2009 Jan; 284(2):1040-9. PubMed ID: 19004824
[TBL] [Abstract] [Full Text] [Related]
7. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
[TBL] [Abstract] [Full Text] [Related]
8. fhit-deficient normal and cancer cells are mitomycin C and UVC resistant.
Ottey M; Han SY; Druck T; Barnoski BL; McCorkell KA; Croce CM; Raventos-Suarez C; Fairchild CR; Wang Y; Huebner K
Br J Cancer; 2004 Nov; 91(9):1669-77. PubMed ID: 15494723
[TBL] [Abstract] [Full Text] [Related]
9. fhit: from gene discovery to cancer treatment and prevention.
Pekarsky Y; Zanesi N; Palamarchuk A; Huebner K; Croce CM
Lancet Oncol; 2002 Dec; 3(12):748-54. PubMed ID: 12473516
[TBL] [Abstract] [Full Text] [Related]
10. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
[TBL] [Abstract] [Full Text] [Related]
11. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
Ishii H; Dumon KR; Vecchione A; Fong LY; Baffa R; Huebner K; Croce CM
JAMA; 2001 Nov; 286(19):2441-9. PubMed ID: 11712940
[TBL] [Abstract] [Full Text] [Related]
12. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract] [Full Text] [Related]
